Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [522]
News [1466]
Articles [67]
Editorials [2]
Conferences [72]
elearning [5]
Reasons to attend the EurocanPlatform translational research course 2015
Dr Wilfried Reichardt, University Medical Center Freiburg, Freiburg, Germany
Reasons to attend the EurocanPlatform translational research course 2015 ( Dr Wilfried Reichardt, University Medical Center Freiburg, Freiburg, Germany )
6 Jan 2015
2nd EurocanPlatform translational research course is good for networking
Dr Diana Montezuma, Portuguese Oncology Institute of Porto, Portugal
2nd EurocanPlatform translational research course is good for networking ( Dr Diana Montezuma, Portuguese Oncology Institute of Porto, Portugal )
6 Jan 2015
Biobanking biological materials and linkage to clinical information
Dr Peter Riegman, Erasmus Medical Center, Rotterdam, The Netherlands
Biobanking biological materials and linkage to clinical information ( Dr Peter Riegman, Erasmus Medical Center, Rotterdam, The Netherlands )
6 Jan 2015
The role of health economics in cancer outcomes research
Prof Bengt Jönsson, Stockholm School of Economics, Stockholm, Sweden
The role of health economics in cancer outcomes research ( Prof Bengt Jönsson, Stockholm School of Economics, Stockholm, Sweden )
6 Jan 2015
Overall survival update from the BREAK-3 study
Prof Axel Hauschild - University Hospital Schleswig-Holstein, Kiel, Germany
Overall survival update from the BREAK-3 study ( Prof Axel Hauschild - University Hospital Schleswig-Holstein, Kiel, Germany )
4 Dec 2014
Ipilimumab may improve outlook of metastatic melanoma in the elderly
Dr Antonio Grimaldi – National Cancer Institute of Napoli, Italy
Ipilimumab may improve outlook of metastatic melanoma in the elderly ( Dr Antonio Grimaldi – National Cancer Institute of Napoli, Italy )
28 Oct 2014
ESMO 2014: News Roundup
ecancer News Team
ESMO 2014: News Roundup ( ecancer News Team )
16 Oct 2014
ESMO 2014 Editor's roundup
Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy
ESMO 2014 Editor's roundup ( Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy )
8 Oct 2014
Ipilimumab extends relapse-free survival in resectable melanoma
Prof Alexander Eggermont - Gustave Roussy, Villejuif, France
Ipilimumab extends relapse-free survival in resectable melanoma ( Prof Alexander Eggermont - Gustave Roussy, Villejuif, France )
2 Oct 2014
Dabrafenib plus trametinib preferable to vemurafenib alone in melanoma
Dr Caroline Robert - Gustave Roussy, Villejuif, France
Dabrafenib plus trametinib preferable to vemurafenib alone in melanoma ( Dr Caroline Robert - Gustave Roussy, Villejuif, France )
29 Sep 2014
Nivolumab potentially superior to standard chemo in advanced melanoma
Dr Jeffrey Weber - Moffitt Cancer Center, Tampa, USA
Nivolumab potentially superior to standard chemo in advanced melanoma ( Dr Jeffrey Weber - Moffitt Cancer Center, Tampa, USA )
29 Sep 2014
Improved response rate and survival with dabrafenib plus trametinib versus...
Dr Caroline Robert - Gustave Roussy, Villejuif, France
Improved response rate and survival with dabrafenib plus trametinib versus vemurafenib alone in melanoma ( Dr Caroline Robert - Gustave Roussy, Villejuif, France )
29 Sep 2014

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation